Search
for
Sort by
Research 181–210 of 1000+
- Acquired scalp alopecia. Part II: A review
- PCOS in Adolescence and Type 2 Diabetes
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Pharmacological Treatment of Alopecia
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Delphi Consensus on Attenuated Androgen Use for Long‐Term Prophylaxis in Hereditary Angioedema: AURA Project
- Hair Follicles: Strategic Targets for Promoting Hair Growth
- Association between Insulin Resistance and Hyperandrogenism among Women with PCOS in Pakistan
- POLYCYSTIC OVARY SYNDROME (PCOS)–AN OVERVIEW
- Evaluation of Androgen Receptor Expression and Its Association with Clinicopathological Features in Iraqi Women with Breast Cancer
- Pathophysiological mechanisms of hair follicle regeneration and potential therapeutic strategies
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Chemical pharmacotherapy options for managing adult acne
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Active pharmaceutical ingredient-ionic liquids assisted follicular co-delivery of ferulic acid and finasteride for enhancing targeted anti-alopecia
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
- Latest Advances in Inflammatory Skin Disease
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- 63452 Silencing key players of androgenetic alopecia pathogenesis in healthy human hair follicles ex vivo highlights the hair growth inhibitory effect of SFRP1
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Intrinsic factors in the pathogenesis of hidradenitis suppurativa: Genetics, hormones, and the microbiome
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Ar/miR-221/IGF-1 Pathway Mediates the Pathogenesis of Androgenetic Alopecia
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)